Ohio Lawmaker Rep. Somani Advocates for Strict Kratom Regulation Over Outright Ban

Ohio Lawmaker Rep. Somani Advocates for Strict Kratom Regulation Over Outright Ban

COLUMBUS, OH – In a significant development for the kratom industry, State Representative Anita Somani (D-Dublin) has publicly voiced her opposition to an outright ban on kratom, instead championing a framework of strict regulation. Her statement, issued on April 13, 2026, came as the Ohio Pharmacy Board considered a proposed rule to classify synthetic kratom as a Schedule 1 drug, a move that would effectively ban its sale in the state. Rep. Somani's stance highlights a growing legislative debate in Ohio, differentiating between prohibition and a controlled market.

What Happened

Rep. Somani, a physician, acknowledged the potential dangers of easily accessible, addictive substances and the necessity for measures to restrict access to kratom. However, she expressed hesitation to endorse a complete ban without sufficient evidence to warrant such a strict measure, arguing that an outright prohibition would push kratom sales onto the black market, thereby preventing proper oversight and regulation of its sales and side effects.

Instead, Rep. Somani outlined a series of proposed regulations she would support. These include restricting access to individuals 21 and over, implementing clear labeling and dosage requirements, banning the most potent forms (implied to include synthetic compounds, which Ohio has since moved to ban permanently), requiring child-proof packaging, mandating recommended serving sizes on packaging, and prohibiting sublingual tab formulations. She also suggested placing kratom products behind the counter in retail settings like gas stations, similar to pseudoephedrine and tobacco products, to ensure stringent ID checks.

Why It Matters to Kratom Merchants and Consumers

Rep. Somani's position offers a potential lifeline for the legal kratom market in Ohio, representing a pragmatic alternative to the total prohibition sought by some, including Governor Mike DeWine, who has advocated for an all-out ban. While Ohio has already implemented a permanent ban on synthetic kratom compounds, effective May 14, 2026, the debate around natural kratom continues, with the Ohio Board of Pharmacy also having moved to classify natural kratom as a Schedule I drug.

For kratom merchants, this indicates that a regulated market, rather than a completely closed one, might still be achievable. For consumers, it suggests continued, albeit more controlled, access to natural kratom products. The ongoing legislative discussions, including those around bills like Senate Bill 299 which seeks to regulate natural kratom, underscore the dynamic nature of kratom policy in Ohio.

Compliance Implications for High-Risk Merchants

The emphasis on "strict regulation" by Rep. Somani aligns with the increasing scrutiny faced by the kratom industry nationwide. For high-risk merchants, this means proactive and rigorous compliance is not merely advisable but essential for continued operation. The types of regulations proposed by Rep. Somani – age restrictions, labeling, packaging, and dosage rules – are foundational elements of responsible kratom commerce.

Merchants must prioritize robust Certificates of Analysis (COAs) and comprehensive lab testing. COAs should verify the absence of synthetic kratom compounds and other adulterants, confirm the potency of key alkaloids (mitragynine and 7-hydroxymitragynine), and demonstrate purity from heavy metals, pesticides, and microbial contaminants. These tests are crucial for consumer safety and regulatory compliance, ensuring products meet any future state-mandated standards.

Furthermore, merchants should prepare for potential requirements such as child-proof packaging, clear and accurate serving size instructions, and stringent age verification protocols at the point of sale. Implementing these best practices now, even before they become law, can position businesses favorably as the regulatory landscape evolves in Ohio and potentially serve as a model for other states considering similar legislative approaches. The ongoing legislative efforts highlight the need for the industry to actively engage with policymakers and demonstrate a commitment to product quality and consumer protection.